Regulation of turnover of tumor suppressor p53 and cell growth by E6-AP, a ubiquitin protein ligase mutated in Angelman mental retardation syndrome

Cellular and Molecular Life Sciences : CMLS
Amit Mishra, Nihar Ranjan Jana

Abstract

E6-AP is a founding member of HECT (homologous to E6-AP C terminus) domain subfamily of E3 ubiquitin ligases. It degrades tumor suppressor p53 in association with the E6 oncoprotein of the human papilloma virus. However, there are conflicting reports on its role in the degradation of p53 in the absence of E6 oncoprotein. Here, we studied the role of E6-AP in regulation of p53 in mouse neuro 2a cells. Overexpression of E6-AP in neuro 2a cells increased the ubiquitylation and degradation of p53, which could be prevented upon deletion of HECT domain. E6-AP also directly ubiquitylated p53 in an in vitro ubiquitylation assay. Partial knockdown of E6-AP increased the levels of p53 and p53-dependent transcription. Partial knockdown also increased neuronal cell death, which may be mediated partly via p53. Our result suggests that E6-AP not only enhances the degradation of p53 but also regulates the neuronal cell growth.

Citations

Sep 25, 2012·Molecular Neurobiology·Deepak ChhanganiAmit Mishra
Oct 7, 2011·Science Translational Medicine·Stephen E P SmithMatthew P Anderson
Oct 5, 2013·Molecular Neurobiology·Jimmy El Hokayem, Zafar Nawaz
Jul 26, 2012·Neural Plasticity·Nihar Ranjan Jana
Jul 14, 2009·Neurobiology of Disease·Amit MishraNihar Ranjan Jana
Sep 13, 2014·Human Mutation·Bekim SadikovicPing Fang
Oct 9, 2012·Neurobiology of Aging·Amit MishraKoji Yamanaka
Apr 29, 2014·Biochimica Et Biophysica Acta·Deepak ChhanganiAmit Mishra
Aug 11, 2010·Neurobiology of Disease·Shalaka A Mulherkar, Nihar Ranjan Jana
May 20, 2011·Trends in Neurosciences·Angela M MabbBenjamin D Philpot
Mar 28, 2009·Cell Death and Differentiation·I Louria-HayonY Haupt
Dec 27, 2012·Molecular Biology Reports·Cong-Cong Hou, Wan-Xi Yang
Sep 24, 2013·Molecular & Cellular Proteomics : MCP·Caroline J DeHartDavid H Perlman
Oct 10, 2013·Journal of Cellular Physiology·Sabita N Saldanha, Trygve O Tollefsbol
Mar 21, 2015·PLoS Computational Biology·Fan YangFrederick P Roth
Jun 20, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Chia-Yu YangTse-Hua Tan
Jan 2, 2018·Oncotarget·Miran RadaSalvador Macip
Jun 6, 2017·Frontiers in Molecular Neuroscience·Arun UpadhyayAmit Mishra
Dec 21, 2018·Frontiers in Molecular Neuroscience·Naman Vatsa, Nihar Ranjan Jana
Mar 7, 2021·Cancers·Mengwu Pan, Christine Blattner
Jan 18, 2014·Learning & Memory·Irina FilonovaEdwin J Weeber

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.